Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Comparison of Depression Interventions After Acute Coronary Syndrome

Phase 1

Completed

Conditions: Acute Coronary Syndrome
Depression

Interventions: Other: Standard care
Behavioral: Problem Solving Therapy
Drug: Sertraline, citalopram, or bupropion

First Posted Date: 2009-12-15

Last Posted Date: 2017-09-13

Lead Sponsor: Columbia University

Target Recruit Count: 150

Registration Number: NCT01032018

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Trustees of the University of Pennsylvania, Penn Cardiac Center at Mercer Bucks, Yardley, Pennsylvania, United States

and more 2 locations

Usefulness of Integrative Medicine Tools As Adjunctive Care for Women After Coronary Artery Bypass Grafting

Phase 1

Completed

Conditions: Cardiovascular Disease

Interventions: Behavioral: Integrative Therapies Intervention

First Posted Date: 2009-11-25

Last Posted Date: 2014-01-29

Lead Sponsor: Columbia University

Target Recruit Count: 100

Registration Number: NCT01020227

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

Phase 1

Completed

Conditions: Juvenile Myelomonocytic Leukemia
Acute Myelogenous Leukemia
Myelodysplastic Syndrome

Interventions: Drug: Anti-Thymocyte Globulin
Drug: Fludarabine
Drug: Isotretinoin
Drug: Busulfan
Drug: GVHD Prophylaxis
Drug: Gemtuzumab Ozogamicin

First Posted Date: 2009-11-25

Last Posted Date: 2021-08-06

Lead Sponsor: Columbia University

Target Recruit Count: 18

Registration Number: NCT01020539

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

Phase 2

Completed

Conditions: Bone Marrow Failure
Osteopetrosis
Fanconi Anemia
Severe Combined Immunodeficiency

Interventions: Drug: Fludarabine
Drug: Busulfan
Drug: Cyclophosphamide
Drug: Alemtuzumab
Drug: Rabbit Anti-thymocyte Globulin
Drug: Horse Anti-thymocyte Globulin

First Posted Date: 2009-11-25

Last Posted Date: 2024-10-31

Lead Sponsor: Columbia University

Target Recruit Count: 38

Registration Number: NCT01019876

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

The Use of Music for Pain and Anxiety Control During Abortion

Not Applicable

Completed

Conditions: Anxiety
Pain

Interventions: Other: iPod Nano digital music player

First Posted Date: 2009-11-13

Last Posted Date: 2012-11-19

Lead Sponsor: Columbia University

Target Recruit Count: 106

Registration Number: NCT01013363

Locations: 🇺🇸
Columbia University, New York, New York, United States

Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Phase 1

Completed

Conditions: Hematopoietic Organs; Disorder

Interventions: Drug: Lactobacillus plantarum strains 299 and 299v

First Posted Date: 2009-11-10

Last Posted Date: 2017-07-13

Lead Sponsor: Columbia University

Target Recruit Count: 31

Registration Number: NCT01010867

Locations: 🇺🇸
Nemours Children's Clinic, Jacksonville, Florida, United States
🇺🇸
All Children's Hospital, Saint Petersburg, Florida, United States
🇺🇸
Columbia Universtiy Medical Center, New York, New York, United States

Adjuvant Valproate for High Grade Sarcomas

Phase 1

Terminated

Conditions: High Grade Sarcoma

Interventions: Drug: Valproic Acid

First Posted Date: 2009-11-10

Last Posted Date: 2015-05-21

Lead Sponsor: Columbia University

Target Recruit Count: 7

Registration Number: NCT01010958

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

Not Applicable

Completed

Conditions: Invasive Breast Cancer

Interventions: Drug: Anastrozole

First Posted Date: 2009-10-30

Last Posted Date: 2021-01-11

Lead Sponsor: Columbia University

Target Recruit Count: 10

Registration Number: NCT01004744

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy

Phase 2

Terminated

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Pemetrexed
Drug: Cisplatin
Drug: Bevacizumab

First Posted Date: 2009-10-20

Last Posted Date: 2024-07-30

Lead Sponsor: Columbia University

Target Recruit Count: 12

Registration Number: NCT00998166

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸
North Shore University Hospital, Lake Success, New York, United States

Study of CellCept for Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Mycophenolate mofetil

First Posted Date: 2009-10-20

Last Posted Date: 2014-04-25

Lead Sponsor: Columbia University

Target Recruit Count: 12

Registration Number: NCT00997958

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy